JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$272.32
-4.00 (-1.45%)
As of Nov 5, 9:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
94.38B
Net Income
26.86B
Gross Margin
68.0%
Profit Margin
28.5%
Rev Growth
+5.6%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.0% 68.0% 44.0% 44.0%
Operating Margin 34.6% 31.1% 29.5% 29.2%
Profit Margin 28.5% 27.0% 19.9% 21.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 94.38B 89.38B 81.19B 89.13B
Gross Profit 64.16B 60.76B 35.72B 39.21B
Operating Income 32.65B 27.82B 23.92B 26.00B
Net Income 26.86B 22.89B 16.19B 19.43B
Gross Margin 68.0% 68.0% 44.0% 44.0%
Operating Margin 34.6% 31.1% 29.5% 29.2%
Profit Margin 28.5% 27.0% 19.9% 21.8%
Rev Growth +5.6% +5.6% +12.0% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 123.10B 123.10B 181.05B 177.00B
Total Equity 209.42B 209.42B 426.62B 418.52B
D/E Ratio 0.59 0.59 0.42 0.42
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 40.16B 36.13B 32.24B 37.61B
Free Cash Flow — — 20.95B 18.85B